SEC Comment Letter 0000000000-24-005859 to EXELIXIS, INC. (EXEL) (CIK 0000939767) (EXEL)
EXELIXIS, INC. (EXEL) (CIK 0000939767)
Date: May 21, 2024 · CIK: 0000939767 · Accession: 0000000000-24-005859
AI Filing Summary & Sentiment
File numbers found in text: 000-30235
Letter
United States securities and exchange commission logo May 21, 2024 Christopher Senner Executive Vice President and Chief Financial Officer EXELIXIS, INC. 1851 Harbor Bay Parkway Alameda, CA 94502 Re:EXELIXIS, INC. Form 10-K for the Year Ended December 29, 2023 Filed February 6, 2024 File No. 000-30235 Dear Christopher Senner: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
May 21, 2024
Christopher Senner
Executive Vice President and Chief Financial Officer
EXELIXIS, INC.
1851 Harbor Bay Parkway
Alameda, CA 94502
Re:EXELIXIS, INC.
Form 10-K for the Year Ended December 29, 2023
Filed February 6, 2024
File No. 000-30235
Dear Christopher Senner:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences